Dr. Natasha Shur has been a medical geneticist for almost twenty years. She earned her medical degree from the Albert Einstein College of Medicine and completed her pediatric residency and genetics training at Montefiore Medical Center. She is board-certified by the American Board of Medical Genetics and Genomics and a member of the Ray Helfer Society and the American College of Medical Genetics and Genomics. 

Dr. Shur’s clinical focus includes supporting multidisciplinary programs such as the Craniofacial Clinic, Vascular Clinic, and the Growth Program for Inflammatory Bowel Diseases. Her academic work is dedicated to child advocacy and growth in the rare disease population. Dr. Shur’s research background includes clinical trial experience ranging from novel treatments in PKU and Niemann-Pick Type C to her recent work on an investigator-initiated trial of steroids in rhabdomyolysis.

Dr. Shur has authored over seventy publications, numerous book chapters, and recently co-edited an issue for Pediatric Annals on Multidisciplinary Growth Perspectives. Her contributions have been recognized with several awards, including teaching awards, awards for excellence in patient care, and the 2021 NORD Rare Impact Award.